PET/CT

Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.

RSS icon
Thumbnail

PET/MRI may reduce unnecessary prostate biopsies by 83%

A study out of China found most patients biopsied for prostate lesions did not have clinically significant cancer, calling the clinical ranking systems into question.

Thumbnail

RLS Radiopharmacies purchases Gallium-68 generators for all its locations

The supply agreement with Eckert & Ziegler will ensure radiopharmaceuticals are available for PET imaging and cancer treatment plans.

Thumbnail

UC San Diego earns $6.7M NIH grant to develop noninvasive imaging to quantify immune cells in tumors

The TAM-Sense technique is currently in pre-clinical development, but it could be used to develop new treatments.

Thumbnail

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Researchers develop new method for early detection of Alzheimer’s

Higher levels of amyloid protein in the blood correlate with MRI images of the brain that are consistent with dementia.

Supply crunch forces ED to develop contrast use mitigation protocol for PE

The protocol led to a reduction in CT scans without sacrificing diagnostic accuracy.

Video interview with ASNC President Lawrence Phillips, MD, NYU, who is encouraging the modernization of nuclear cardiology labs and expansion into new diagnostic areas.

ASNC president pushes to modernize nuclear cardiology, expand the specialty's reach

ASNC President Lawrence Phillips, MD, wants to see nuclear cardiologists modernize their labs and embrace new strategies for the evaluation of amyloidosis, sarcoidosis and inflammation.

Timothy Bateman, MD, co-director, cardiovascular radiologic imaging program, Saint Luke's Mid America Heart Institute, professor of medicine at the University of Missouri-Kansas City School of Medicine, and an ASNC past-president, is one of the authors on the AURORA study. He spoke with Cardiovascular Business about the study and what it is like to work with flurpiridaz.

Flurpiridaz will have a major impact on cardiac PET and nuclear imaging

The new radiotracer flurpiridaz is poised to make a major impact on nuclear cardiology. Timothy Bateman, MD, co-director of the cardiovascular radiologic imaging program at Saint Luke's Mid America Heart Institute, shared details on the tracer in a new interview. 

Displaying 25 - 32 of 113
Design by Adaptive Theme